ArticleThe oncologist2025

Prognostic index for predicting outcomes of trastuzumab deruxtecan in HER2 expressing metastatic breast cancer: a real-world multicenter study.

Cong Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.